I supported the creation of a pathway for biosimilars, and for empowering FDA with the authority and resources to ensure that biosimilars are safely available here in the U.S. for the patients that need them the most.
Pitts discusses his support for biosimilar approval pathways to benefit patients.
Share
More from Joe Pitts
It is unfortunate that we have a Congress of the United States, the majority parties that want to just tear down this law.
I for one in a portion of my life when I was a boy lived in a household where we didn't have access to health care.
Both the FDA and the General Accountability Office agree that there is no food safety justification for this regulatory divide.
Today's hearing will be taking a close look at the United States Preventive Services Task Force, created in 1984 as an independent, volunteer panel of 16 national experts in prevention, primary care, and evidence-based medicine and tasked…
Other voices in this conversation
